Workflow
Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
JAZZJazz Pharmaceuticals(JAZZ) Prnewswire·2024-09-03 19:00